{
    "code": 0,
    "data": [
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find attached herewith revised intimation of Conference Call on Q3FY26 and 9MFY26 financial results - Change in Conference Call Timing.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b6727c6e-a66f-4882-b4a4-081d625ddd88.pdf",
            "news_date": "2026-02-12 11:16:00"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Scheme of Arrangement",
            "caption": "Announcement under Regulation 30 (LODR)-Scheme of Arrangement",
            "news_body": "Please Find Attached Herewith Intimation under Regulation 30 SEBI LODR 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b550bb1-7c18-492a-be09-0bd462e64a11.pdf",
            "news_date": "2026-02-06 13:55:04"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we write to inform you that a conference call to discuss the Q3 and 9MFY26 financial results will be held on Friday February 13 2026 at 04.00 p.m.\r\n\r\nPlease find attached herewith the conference call details.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83d33d87-1700-4130-b130-a9a3362ef567.pdf",
            "news_date": "2026-01-23 18:05:24"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting Intimation For Notice Of Meeting Of Board Of Directors Of Alkem Laboratories Limited.",
            "news_body": "Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve (i) the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended 31st December 2025; and (ii) Interim Dividend for financial year 2025-2026.\r\n\r\nThe record date for the purpose of payment of Interim Dividend for financial year 2025-2026 would be Friday 20th February 2026 subject to declaration of the said Interim Dividend by the Board of Directors in its meeting to be held on 13th February 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c13786b5-0632-404d-a129-8bfd6c4a9936.pdf",
            "news_date": "2026-01-23 13:30:37"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI LODR",
            "news_body": "Please find attached herewith disclosure in respect of order passed by the Statutory Authority.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc2e283a-2ade-4d74-ae79-e1b14ef8e865.pdf",
            "news_date": "2026-01-22 15:14:52"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for ICICI Prudential Mutual Fund",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0EE34E4A_3780_4C95_AE26_9675F5527A8A_101836.pdf",
            "news_date": "2026-01-17 10:18:40"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI LODR",
            "news_body": "Please find attached herewith disclosure in respect of order passed by Statutory Authority.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c26908d-a84e-41d5-a238-ae5693def9cb.pdf",
            "news_date": "2026-01-13 16:26:02"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Please find attached herewith Press release on Alkem launches Renocia cyclical therapy a nutritional supplements kit to support hair growth.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78e0ca74-396c-4c49-a95e-e64180ff6075.pdf",
            "news_date": "2026-01-08 15:03:16"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI LODR",
            "news_body": "Please find attached herewith disclosure in respect of order passed by the Statutory Authority.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57c1498b-f968-482d-8bf4-5b18f9603edb.pdf",
            "news_date": "2026-01-01 12:32:54"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
            "news_body": "Please find attached herewith Disclosure under Regulation 30 of SEBI LODR- Update on transfer of the trade generics business of the company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=24c1b6ac-b0a4-4fe2-b51b-4db5fe30fc1e.pdf",
            "news_date": "2025-12-30 17:10:38"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI LODR.",
            "news_body": "Please find attached herewith Disclosure in respect of order passed by Statutory Authority.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ac8dec2-182a-4a58-b784-dfd57e589c2a.pdf",
            "news_date": "2025-12-30 16:10:37"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI LODR.",
            "news_body": "Please find attached herewith Disclosure in respect of order passed by Statutory Authority.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06600916-edb7-44a1-aa9e-1d9ad1a9069a.pdf",
            "news_date": "2025-12-30 13:11:40"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI LODR.",
            "news_body": "Please find attached herewith Disclosure in respect of order passed by Statutory Authority.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=926859c5-9c5c-4e59-97da-d39a96a1b1e2.pdf",
            "news_date": "2025-12-30 12:26:18"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI LODR.",
            "news_body": "Please find attached herewith Disclosure in respect of order passed by Statutory Authority.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53e276fb-9904-4db1-8db8-0234bca54d44.pdf",
            "news_date": "2025-12-29 15:05:32"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Please find attached herewith Disclosure under Regulation 30 of SEBI LODR Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=04012bcb-148e-42bc-a069-9a960dec8bba.pdf",
            "news_date": "2025-12-26 19:01:37"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI.",
            "news_body": "Please find attached herewith Disclosure in respect of order passed by Statutory Authority.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7283f7f4-6ba9-44a7-ad9b-377e71365e0d.pdf",
            "news_date": "2025-12-26 18:34:16"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "This is to inform you that the trading window will remain closed from 30th December 2025 until the expiry of 48 hours after the date on which the financial results of the Company for the quarter and nine months ended 31st December 2025 are communicated to the stock exchanges.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=adaaf4bd-385c-4bbf-ae0b-013e573abfa9.pdf",
            "news_date": "2025-12-23 15:00:40"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find attached herewith Schedule of Analyst/Investor Meet.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b4063fdf-2488-415c-a16a-735e3d613a72.pdf",
            "news_date": "2025-12-23 11:49:23"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "This  is to inform you that Mr. Suresh Sawant  has been appointed at Senior Management Position in the company effective from 16th December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a049c2e5-216a-4a60-a9f6-aef6157cdc79.pdf",
            "news_date": "2025-12-16 11:13:48"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find herewith Schedule of Analyst/Investor meetings.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d7eb4c0-55b4-41a8-b61f-2e31398507a2.pdf",
            "news_date": "2025-12-15 17:23:35"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "This is to inform you that Mr. Vijay Shetty shall cease to hold Senior Management Position of the company effective from 12th December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc17a352-fa18-4ced-a27f-2d959f1bd6d3.pdf",
            "news_date": "2025-12-12 12:50:07"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached herewith a copy of Newspaper Advertisement published today.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=45039eb2-bfcb-4233-b070-06ca06f3d1c3.pdf",
            "news_date": "2025-12-12 12:43:55"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "GMP Inspection By Malta Medicines Authority At CompanyS Manufacturing Facility Located At Daman India",
            "news_body": "Closure of GMP Inspection by Malta Medicines Authority at Companys manufacturing facility located at Daman India.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83fe8b37-7893-4509-b4fc-881a33f3e86a.pdf",
            "news_date": "2025-12-10 10:43:42"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find attached herewith schedule of Analyst/Investor meetings.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2fbc4001-9d06-499d-a5a1-a661ac5a3d18.pdf",
            "news_date": "2025-12-08 15:15:57"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "This is to inform you that Mr. Rakesh Tripathi shall cease to hold Senior Management Position of the Company effective from \r\n8th December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a094a21f-7cad-4332-a6b5-d509d513dbb1.pdf",
            "news_date": "2025-12-08 11:27:21"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "This is to inform you that Mr. Prakash Ramnani has been appointed at senior management position in the company effective from 05th December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a82ecae-9130-49a4-8694-e100bd103c33.pdf",
            "news_date": "2025-12-05 16:30:20"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "This is to inform you that Mr. Prakash Ramnani has been appointed at senior management position in the company effective from 05th December2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c5ecdf26-b88b-4f0b-bf1e-cf9607bebd31.pdf",
            "news_date": "2025-12-05 16:04:07"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI .",
            "news_body": "Please find attached herewith Disclosure in respect of order passed by Statutory Authority.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f5dade8-3bda-437d-8797-cfd180bd67c9.pdf",
            "news_date": "2025-12-04 13:39:39"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Analyst / Investor Meet - Intimation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3b5a1c2-3640-4e64-80a6-c0692ee2ba06.pdf",
            "news_date": "2025-12-03 13:22:40"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Sustainability Report For Financial Year 2024-2025.",
            "news_body": "Please find enclosed herewith Sustainability Report for Financial year 2024-25.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d634600-693a-43bd-9d96-875e73f2a54b.pdf",
            "news_date": "2025-12-02 14:53:32"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Analyst / Investor Meet - Intimation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72d8b2f4-7a56-4e41-8bbf-b069dce5a3db.pdf",
            "news_date": "2025-11-25 10:41:25"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "GMP Inspection By Ministry Of Health Armenia At The Companys Manufacturing Facility Located At Sikkim India",
            "news_body": "Closure of GMP Inspection by Ministry of Health Armenia at the Companys manufacturing facility located at Sikkim India.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e9f909fd-872b-48b5-85f9-31414ee13953.pdf",
            "news_date": "2025-11-22 21:09:49"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release - ALkem launches probiotic \"DSS\" the original De Simone formulation in India for gut health management",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83fbce48-e5a7-496a-8881-9c1092eb37d1.pdf",
            "news_date": "2025-11-20 16:58:09"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q2 & H1 FY26 - Earnings Conference Call Transcript",
            "news_id": "9f6efc06-9e14-492a-8fa7-34858daa2251",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ecd03561-909d-4fcd-b57b-fb455bd2da51.pdf",
            "news_date": "2025-11-19 11:55:22",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q2 & H1 FY26 - Earnings Conference Call Transcript",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ecd03561-909d-4fcd-b57b-fb455bd2da51.pdf",
            "news_date": "2025-11-19 11:55:22"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI LODR.",
            "news_body": "Pursuant to Regulation 30 of SEBI LODR Regulation2025 this is to inform you that the Company has received an order passed by the statutory authority under the Goods and Services Tax Act2017. The relevant disclosure is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b24a5f8d-8a3e-46ec-9a24-5fbca5718dc3.pdf",
            "news_date": "2025-11-18 17:19:39"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement- Disclosure under Regulation 30",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6209ba25-c529-4bdd-9335-aaa6ff131dbe.pdf",
            "news_date": "2025-11-14 16:10:14"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find enclosed herewith the details of the Analyst / Institutional Investor meetings.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22316927-0d47-4e3a-93ef-05d917ec1d8d.pdf",
            "news_date": "2025-11-14 15:58:15"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the audio recording of the  Q2 & H1FY26 Earnings Conference Call is available on the website of the Company.",
            "news_id": "6638b9a1-f183-407a-8c2f-5510ff939d3f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5e47c811-9bc3-4aaa-9b45-73b7414e2cec.pdf",
            "news_date": "2025-11-13 20:58:03",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the audio recording of the  Q2 & H1FY26 Earnings Conference Call is available on the website of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5e47c811-9bc3-4aaa-9b45-73b7414e2cec.pdf",
            "news_date": "2025-11-13 20:58:03"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "The financial results of the Company for the quarter and half year ended 30th September 2025 having been communicated to the Stock Exchanges today i.e. 13th November 2025 the trading window shall open on 17th November 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c2e5eb1-a9a6-4cee-bbd1-2bc10878f4a7.pdf",
            "news_date": "2025-11-13 14:03:39"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pls find enclosed herewith the press release and analyst presentation on Q2 and H1FY26 earnings and business updates of the Company.",
            "news_id": "76acd530-5255-4421-b801-c07d3c783608",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6491c139-e5e1-45cd-b7d3-06397d76eafe.pdf",
            "news_date": "2025-11-13 13:59:17",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pls find enclosed herewith the press release and analyst presentation on Q2 and H1FY26 earnings and business updates of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6491c139-e5e1-45cd-b7d3-06397d76eafe.pdf",
            "news_date": "2025-11-13 13:59:17"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025",
            "news_body": "Pls find enclosed herewith the Unaudited Financial Results along with the LRR for the quarter and half year ended 30 September 2025.",
            "news_id": "8065e63f-cc21-47e1-9542-48e848623475",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5525273b-314a-433f-9fc2-d09b39fcf1aa.pdf",
            "news_date": "2025-11-13 13:55:21",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025",
            "news_body": "Pls find enclosed herewith the Unaudited Financial Results along with the LRR for the quarter and half year ended 30 September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5525273b-314a-433f-9fc2-d09b39fcf1aa.pdf",
            "news_date": "2025-11-13 13:55:21"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Dated 13 November 2025",
            "news_body": "Pls find enclosed the Outcome of Board Meeting dated 13.11.2025. \r\n\r\nKindly take the same on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=647bb843-5dc6-4d3f-82d6-f1c0d01e37e8.pdf",
            "news_date": "2025-11-13 13:48:44"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "EU GMP Inspection By German Health Authority At AlkemS Manufacturing Facility Located At Baddi India",
            "news_body": "Closure of EU GMP inspection by German Health Authority at Alkems manufacturing facility located at Baddi India",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=733d7ded-59bb-4aa3-ad4b-1e0490847d9a.pdf",
            "news_date": "2025-11-10 19:00:11"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI LODR - Regulatory Order",
            "news_body": "Pursuant to Regulation 30 read with SEBI LODR regulations this is to inform you that the Company has received order passed by statutory authority under the Goods and Service Tax Act 2017. The relevant disclosure is enclosed herewith",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c3ba588-038e-41e4-9ce6-2db030c90898.pdf",
            "news_date": "2025-11-03 16:17:22"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release (Revised)",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)",
            "news_body": "Press Release- Alkem Foundation and IIT Bombay announce strategic collaboration to set up advanced research centre for immuno-therapeutics and regenerative medicines",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7a7464a-0c69-430f-8073-e7a263e8c605.pdf",
            "news_date": "2025-11-03 14:17:20"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release - Alkem and IIT Bombay announce strategic collaboration to set up advanced research centre for immuno-therapeutics and regenerative medicines.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8082fbe-df97-4734-a42f-47d37e3cb04e.pdf",
            "news_date": "2025-11-03 13:03:48"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we write to inform you that a conference call to discuss the Q2 and H1FY26 financial results will be held on Thursday November 13 2025 at 04.30 p.m.\r\n\r\nPlease find attached herewith the conference call details.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=695d82d0-00c0-43aa-8d7c-28e0a96c2dc9.pdf",
            "news_date": "2025-10-28 16:11:22"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we write to inform you that a conference call to discuss the Q2 and H1FY26 financial results will be held on Thursday November 13 2025 at 04.30 p.m.\r\n\r\nPlease find attached herewith the conference call details.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4dc83dae-8435-4b38-91e5-318e38f75932.pdf",
            "news_date": "2025-10-28 15:02:25"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Notice Of Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On 13Th November 2025",
            "news_body": "Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and half year ended 30th September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d782195b-baaa-41c6-bc29-1132e75316a0.pdf",
            "news_date": "2025-10-23 17:11:38"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI LODR - Regulatory Order",
            "news_body": "Pursuant to Regulation 30 read with SEBI LODR Regulations this is to inform you that the Company has received an appeal order passed by statutory authority under the Goods and Services Tax Act 2017. The relevant disclosure is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07278b06-e9ef-46cd-8e1e-b3a6f0375c11.pdf",
            "news_date": "2025-10-01 15:11:05"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Reg 30 (LODR)- Alkem Laboratories Limited Entered Into A Business Transfer Agreement With Alkem Wellness Limited A Wholly Owned Subsidiary Of The Company.",
            "news_body": "This is to inform you that today i.e. 26th September 2025 the Company has entered into a Business Transfer Agreement with Alkem Wellness Limited a wholly owned subsidiary of the Company for transfer of the trade generics business as a going concern on a slump sale basis effective from 01st October 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e3a6c187-f9ed-496b-8b09-7bbd1d379441.pdf",
            "news_date": "2025-09-26 17:28:14"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "This is to inform you that the trading window will remain closed from 29th September 2025 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter and half year ended 30th September 2025 are communicated to the Stock Exchanges.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e054c397-d7b8-4fd8-a64c-0914c8acbb53.pdf",
            "news_date": "2025-09-25 15:50:08"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "This is to inform you that Mr. Amit Ghare a Senior Management Personnel has tendered his resignation from the services of the Company on account of personal commitments effective from 30th September 2025. Accordingly Mr. Amit Ghare shall cease to hold Senior Management Position of the Company effective from the said date i.e 30th September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79748eec-3651-43da-aae5-f8cebd6054d6.pdf",
            "news_date": "2025-09-25 15:29:17"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI LODR - Regulatory Order",
            "news_body": "Pursuant to Regulation 30 of SEBI LODR Regulations this is to inform you that the Company has received an order passed by the statutory authority under the Goods and Services Tax Act 2017. The relevant disclosure is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5677616f-53aa-4c81-8cb2-6a7ed1e6cc51.pdf",
            "news_date": "2025-09-24 14:30:51"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI LODR - Regulatory Order",
            "news_body": "Pursuant to Regulation 30 of SEBI LODR Regulation 2015 this is to inform you that the Company has received an order passed by the statutory authority under the Goods and Services Tax Act 2017. The relevant disclosure is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a1e5c9e-9c0b-48c6-bfc5-5331821837d2.pdf",
            "news_date": "2025-09-22 20:30:32"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "This is to intimate you that Alkem Laboratories Limited (the Company) launches Pertuza a pertuzumab biosimilar in India for treatment of HER2-positive breast cancer.\r\n\r\n A press release in this regard is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=efee6da1-32aa-445a-9f77-72a747916930.pdf",
            "news_date": "2025-09-22 16:04:14"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find enclosed herewith the details of investor meetings scheduled to be held on 25th September 2025 26th September 2025 and 30th September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83579bc8-72ad-48fb-a93f-4d5ade8a3849.pdf",
            "news_date": "2025-09-18 12:39:10"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find enclosed herewith the details of investor meeting scheduled to be held on 22nd September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a87343e4-5bf8-4648-b58a-d09224cdb8d5.pdf",
            "news_date": "2025-09-17 15:49:13"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find enclosed herewith the details of investor meetings scheduled to be held on 22nd September 2025 and 25th September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f1a2f92b-d195-4811-aa7a-8407f7b6ed66.pdf",
            "news_date": "2025-09-16 18:58:56"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Reg 30 (LODR)- Cancellation Of Analyst / Institutional Investor Meeting Scheduled On Tuesday 09Th September 2025.",
            "news_body": "In continuation to our intimation dated 03rd September 2025 this is to inform that the Analyst / Investor meeting as scheduled to be held on Tuesday 09th September 2025 has been cancelled.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=249a6882-4386-44fb-aa90-b7a1543d6baa.pdf",
            "news_date": "2025-09-09 12:28:22"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find enclosed herewith the details of investor meetings scheduled to be held on 12th September 2025 17th September 2025 18th September 2025 19th September 2025 and 23rd September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d003df6-75c7-4098-acc8-9cf7ada4adc1.pdf",
            "news_date": "2025-09-08 12:28:33"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find enclosed herewith the details of investor meeting scheduled to be held on 09th September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d24c174-16c1-4b54-94f7-8142a64994e3.pdf",
            "news_date": "2025-09-03 10:41:51"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Details regarding the brief proceedings of the 51st AGM and the voting results of the business transacted thereat along with the Report of the Scrutinizer on remote e-voting and e-voting during the AGM are enclosed herewith.\r\n\r\nKindly take the same on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d16a074-45ed-4374-b286-d94c314d3efc.pdf",
            "news_date": "2025-08-25 16:41:11"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Details regarding the brief proceedings of the 51st AGM of the Company and voting results of the business transacted thereat alongwith the report of the Scrutinizer on remote e-voting and e-voting during the AGM are enclosed herewith.\r\n\r\nRequest you to kindly take the same on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85cfec63-cb5b-4943-b1b2-6c5bcd112662.pdf",
            "news_date": "2025-08-25 16:31:34"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find enclosed herewith the details of investor meetings scheduled to be held on 28th August 2025 and 03rd September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86b8ba95-4a09-471b-9b27-0a9084642b91.pdf",
            "news_date": "2025-08-22 13:52:11"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "This is to inform you that the Company has announced the launch of Olesoft Trucera moisturizing lotion an advanced science-led formulation designed to restore hydration strengthen the skin barrier and soothe skin flare ups with an inside out approach. A press release in this regard is enclosed herewith.\r\n\r\nKindly take the same on record.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fddf8a80-c72c-46a5-a760-99b8f406bc5a.pdf",
            "news_date": "2025-08-19 12:53:05"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith the transcript of \"Q1 FY2026 Earnings conference call\" hosted by the Company on Tuesday 12th August 2025.",
            "news_id": "75eeacbb-4131-44aa-830d-59e45c6dbdd1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0cd83f78-d535-4c6a-85a2-5f4a74bb6a9c.pdf",
            "news_date": "2025-08-19 10:38:43",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith the transcript of \"Q1 FY2026 Earnings conference call\" hosted by the Company on Tuesday 12th August 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0cd83f78-d535-4c6a-85a2-5f4a74bb6a9c.pdf",
            "news_date": "2025-08-19 10:38:43"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find enclosed herewith link for Audio Recording of Earnings Call for Q1FY26",
            "news_id": "35ca0894-00a4-46f6-acbe-095d80078801",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c8792fe7-c9fe-43c3-9a26-3f8f3c8c5245.pdf",
            "news_date": "2025-08-12 20:45:26",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find enclosed herewith link for Audio Recording of Earnings Call for Q1FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c8792fe7-c9fe-43c3-9a26-3f8f3c8c5245.pdf",
            "news_date": "2025-08-12 20:45:26"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "The Financial Results of the Company for the quarter ended 30th June 2025 having been communicated to the Stock Exchange today the trading window shall open on 18th Aug 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=51b4d9c6-8481-4045-a5cd-0188e39e227e.pdf",
            "news_date": "2025-08-12 13:39:45"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed press release and analyst presentation on Q1FY26 earnings and business updates of the Company.",
            "news_id": "1992179e-4b7c-4b31-9a4a-bdf6851accbf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e1f8c5cb-6cae-4760-a9b6-7a66c0c675f3.pdf",
            "news_date": "2025-08-12 13:37:36",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed press release and analyst presentation on Q1FY26 earnings and business updates of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e1f8c5cb-6cae-4760-a9b6-7a66c0c675f3.pdf",
            "news_date": "2025-08-12 13:37:36"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Company has pursuant to shareholders agreement dated 12th Aug 2025 agreed to incorporate a subsidiary Company in the Kingdom of Saudi Arabia.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a6e3abe8-2bd0-4b99-9e13-a126de1dd7a6.pdf",
            "news_date": "2025-08-12 13:35:35"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Unaudited Financial Results For Quarter Ended June 30 2025",
            "news_body": "Please find enclosed herewith unaudited financial results along with LRR for quarter ended 30th June 2025.",
            "news_id": "3503ef0d-92df-480e-ab22-4fe371c4f855",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea91a609-60ad-46b1-8ed3-a996c6833f70.pdf",
            "news_date": "2025-08-12 13:32:37",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Results- Unaudited Financial Results For Quarter Ended June 30 2025",
            "news_body": "Please find enclosed herewith unaudited financial results along with LRR for quarter ended 30th June 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea91a609-60ad-46b1-8ed3-a996c6833f70.pdf",
            "news_date": "2025-08-12 13:32:37"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The BM Dated 12Th Aug 2025",
            "news_body": "Please find enclosed herewith outcome of the BM dated 12th Aug 25. The meeting of BOD started at 11 am and concluded at 1.25 pm.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=372c0f6d-852f-4dcd-a230-cb485798aaee.pdf",
            "news_date": "2025-08-12 13:28:24"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find enclosed herewith the details of investor meeting scheduled to be held on 20th August 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42719fe5-8b80-4622-8fd2-569c10f24927.pdf",
            "news_date": "2025-08-11 12:53:08"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and our earlier intimation dated 05th August 2025 we write to inform you that a conference call to discuss the Q1FY26 financial results will now be held on Tuesday 12th August 2025 at 05.00 p.m.\r\n\r\nPlease find attached herewith the revised conference call details.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc0f7b96-32fa-4ca9-a652-4e025dd9fcef.pdf",
            "news_date": "2025-08-07 15:21:48"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we write to inform you that a conference call to discuss the Q1 FY26 financial results will be held on Tuesday 12th August 2025 at 04.30 p.m.\r\n\r\nPlease find attached herewith the conference call details.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8656771d-5d54-4667-9144-9fcaf33d94da.pdf",
            "news_date": "2025-08-05 16:32:45"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Notice Of Meeting Of Board Of Directors Of The Company Scheduled To Be Held On 12Th August 2025.",
            "news_body": "Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve the Standalone and Consolidated unaudited Financial Results of the Company for the quarter ended 30th June 2025. \r\n\r\nKindly take note of the same.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11c4c173-3c65-4f4f-8ae6-5dc9b572b101.pdf",
            "news_date": "2025-08-04 15:27:33"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
            "news_body": "Please find attached herewith the details regarding the voting results of the business transacted through the Postal Ballot by e-voting process in the prescribed format along with the Scrutinizers Report.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5745eb4f-5317-4421-b2a9-89f2dcf50cae.pdf",
            "news_date": "2025-08-04 13:42:26"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "Please find attached herewith the details of regarding the voting results of the business transacted through Postal Ballot by remote e-voting process in the prescribed format along with the Scrutinizers Report.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c32a633-8029-4d2d-b883-ec392ba4589b.pdf",
            "news_date": "2025-08-04 13:32:05"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI LODR - Regulatory Order",
            "news_body": "Pursuant to Regulation 30 of SEBI LODR Regulations 2015 this is to inform you that the Company has received an order passed by statutory authority under the Goods and Services Tax Act 2017. The relevant disclosure is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b8d79387-b680-4910-ab6b-f64dbb63e712.pdf",
            "news_date": "2025-07-25 22:20:04"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Pursuant to Regulation 30 and 47 read alongwith Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith a copy of advertisement published in todays Newspapers viz. Business Standard (English) and Mumbai Lakshadeep (Marathi) informing about completion of dispatch of Notice of the 51st AGM (including details of e-voting facility) alongwith Annual Report for financial year 2024-25 through electronic mode.\r\n\r\nThe same is also available on the website of the Company at www.alkemlabs.com.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=197dbcd8-c009-42cb-ab1d-a5f426e0f478.pdf",
            "news_date": "2025-07-22 12:57:39"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "Please find enclosed herewith the Business Responsibility and Sustainability Report for the financial year ended 31st march 2025.\r\n\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e437ed77-67e1-4fc6-a9e4-d369554884e4.pdf",
            "news_date": "2025-07-21 16:23:02"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Notice Of 51St Annual General Meeting And Annual Report For FY 2024-25",
            "news_body": "Please find attached herewith the Notice of AGM alongwith the Annual Report for FY 2024-15",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c4b6941a-cd7c-4cc1-a1eb-f48c5a12e58d.pdf",
            "news_date": "2025-07-21 16:14:31"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Please find enclosed herewith the Notice of the 51st Annual General Meeting of the Company scheduled to be held on Monday 25th August 2025 at 11.00 a.m. through Video Conferencing (VC)/ Other Audio Visual Means (OAVM) alongwith the Annual Report for financial year 2024-2025.\r\n\r\nThe same is also available on the website of the Company at www.alkemlabs.com.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08670de9-d763-4d1b-9412-f1524ad094d0.pdf",
            "news_date": "2025-07-21 16:07:59"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Approval For Reclassification Under Regulation 31A Of SEBI LODR Regulations 2015",
            "news_body": "Pursuant to the provisions of Regulation 31A(8)(d) of the SEBI LODR Regulations 2015 as amended we wish to inform you that the Stock Exchanges vide their respective letters dated 15th July 2025 have given their approval for the reclassification of Mr. Shikhar Raj Ms. Sadhika Raj Ms. Sakshi Sinha and Mr. Satyam Sinha from the Promoter Group category to Public category.\r\n\r\nA copy of the approval letters received from the Stock Exchanges are enclosed herewith for your reference.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ea806ab-a464-45dc-964a-8bb862b46154.pdf",
            "news_date": "2025-07-16 11:54:32"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "Please find attached herewith the details of regarding the voting results of the businesses transacted through Postal Ballot by remote e-voting process in the prescribed format along with the Scrutinizers Report.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=96bac707-543e-45ab-a449-8a71558f23dc.pdf",
            "news_date": "2025-07-14 16:46:18"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
            "news_body": "Please find attached herewith the details regarding the voting results of the businesses  transacted through the Postal Ballot by e voting process in the prescribed format along with the Scrutinizers Report.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b1d7f32-4e54-47e8-8227-b2d473446470.pdf",
            "news_date": "2025-07-14 16:41:29"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Pursuant to Regulation 30 of the SEBI LODR Regulations we wish to inform you that Mr. Arun Kumar Purwar (DIN: 00026383) Ms. Sudha Ravi (DIN: 06764496) and Ms. Sangeeta Singh                 (DIN: 06920906) shall retire from the Board of Directors of the Company after the close of business hours on 12th July 2025 upon completion of their second term as Independent Directors of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ab390a4-7b16-46f4-9e74-3c43e898f531.pdf",
            "news_date": "2025-07-08 16:20:03"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Pursuant to Regulation 47 of SEBI LODR Regulations please find attached herewith a copy of the advertisement published in todays newspaper viz. Business Standard (English) and Mumbai Lakshadeep (Marathi) regarding Postal Ballot Notice and e-voting information.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2597c18a-89b8-4860-af14-4ea1f60ed92b.pdf",
            "news_date": "2025-07-04 15:43:41"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Pursuant to Regulation 47 of SEBI LODR  Regulation please find attached herewith a copy of the advertisement published in todays newspaper viz. Business Standard (English) and Mumbai Lakshadeep (Marathi) for information regarding 51st Annual General Meeting of the Company to be held through  VC/OAVM.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9776c03-7895-4b15-974e-8896da694889.pdf",
            "news_date": "2025-07-03 16:42:21"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "Please find attached herewith the Postal Ballot Notice dated 18th June 2025 for the business as specified in the said Notice.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a55e0330-2227-49a1-86b3-de6f2ad445c0.pdf",
            "news_date": "2025-07-03 15:37:31"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "This is to inform you that the trading window will remain closed from 29th June 2025 until the expiry of 48 hours after the date on which the Financial Results of the Company for quarter ended 30th June 2025 are communicated to the Stock Exchanges.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac74887d-61f4-47ee-be21-d7802de9962f.pdf",
            "news_date": "2025-06-27 12:40:43"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Pursuant to Regulation 47 of SEBI LODR please find enclosed herewith a copy of advertisement published in todays newspaper viz. Business Standard (English) and Mumbai Lakshadeep (Marathi) in relation to unclaimed/ unpaid Final Dividend for the FY 2017-18.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df823f29-b515-45f0-b132-68bb22ab6433.pdf",
            "news_date": "2025-06-24 13:30:48"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
            "news_body": "In continuation of our earlier intimation letter dated 07th January 2025 we wish to inform you that today i.e. on 23rd June 2025 the sale and transfer of the Companys manufacturing facility in Madhya Pradesh stands completed in accordance with the conditions prescribed in the Business Transfer Agreement dated 06th January 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d5fa30e5-06f0-43a0-8f6d-f9d414604a5c.pdf",
            "news_date": "2025-06-23 21:41:08"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "The Board of Directors at its meeting held today i.e. 18th June 2025 has approved the appointment of Mr. Diwakar Gupta as an Independent Director of the Company for a term of 5 consecutive years w.e.f. 13th July 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54ed6337-505c-4d25-8ee3-d87726265509.pdf",
            "news_date": "2025-06-18 13:04:46"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI LODR - Regulatory Order",
            "news_body": "Pursuant to Regulation 30 of SEBI LODR Regulations 2015 this is to inform you that the Company has received an order passed by the statutory authority under Goods and Services Tax Act 2017. The relevant disclosure is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a473d9a2-8af5-4ede-97f4-fdc69db41644.pdf",
            "news_date": "2025-06-13 22:11:12"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed herewith a copy of the newspaper advertisement published in todays newspapers regards Postal Ballot Notice and e-voting information.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d22df4c-d6f2-4c6f-b3f2-a41b9658a929.pdf",
            "news_date": "2025-06-13 12:20:41"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "Please find attached herewith the Postal Ballot Notice dated 29th May 2025 for the businesses as specified in the said notice.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7759134b-2343-4ffd-95c1-4c1396f025ca.pdf",
            "news_date": "2025-06-12 13:47:37"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find enclosed herewith the details of investor meeting scheduled to be held on 18th June 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9253163-6894-4a4f-b92f-0b5eddf573a1.pdf",
            "news_date": "2025-06-12 11:43:27"
        },
        {
            "co_code": 19299,
            "bse_code": 539523,
            "isin": "INE540L01014",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find enclosed herewith the details of investor meeting scheduled to be held on 17th June 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7b49ea6f-56bb-43bd-839a-90c33c0d62fb.pdf",
            "news_date": "2025-06-11 11:55:54"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith the transcript of \"Q4 FY2025 Earnings Conference Call\" hosted by the Company on Thursday 29th May 2025.",
            "news_id": "979cc648-89fc-4414-bc04-96e21a809dfb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee0be198-db18-479e-88c2-1338f8249b2f.pdf",
            "news_date": "2025-06-02 13:00:51",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find enclosed herewith link for Audio Recording of Earnings Call for Q4FY25",
            "news_id": "71954f84-3b09-445f-b146-ceb806867ed8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=81db8eca-8752-4d33-892a-4ee4b1a8d71d.pdf",
            "news_date": "2025-05-29 21:27:53",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed press release and analyst presentation on Q4FY25 and FY25 earnings and business updates of the Company",
            "news_id": "b64e99ec-12c2-40e9-9deb-45194af87b56",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71c50ff3-d72d-4199-bccb-033e5693691e.pdf",
            "news_date": "2025-05-29 14:13:29",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Please Find Enclosed Herewith The Outcome Of Board Meeting Dated 29Th May 2025.\r\n\r\n\r\n\r\n\r\nKindly Take The Same On Record.\r\n",
            "news_body": "Please find enclosed Audited Financial Results along with Auditors Report for FY ended 31st march 25",
            "news_id": "5623b976-01c9-4cf3-a70a-e5f31745b1bf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eea44f2e-4fcb-417a-aa7b-eafa677831ed.pdf",
            "news_date": "2025-05-29 14:01:17",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith the presentation with respect to the Investor / Analyst Meeting scheduled to be held at HSBC Global Investment Summit 2025 on 24th March 2025 and 25th March 2025 at Hong Kong.",
            "news_id": "9dfbf119-b0c6-4bf5-a98f-14b6f59b324a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=111cd47b-bf95-48b5-87c1-5a8fbed12ef4.pdf",
            "news_date": "2025-03-19 16:57:14",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith the transcript of \"Q3 FY2025 Earnings Conference Call\" hosted by the Company on Friday 07th February 2025.",
            "news_id": "ec9240b2-8533-454f-9bfb-902ee3d79816",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=667168ff-f380-4900-b24c-305bf284e725.pdf",
            "news_date": "2025-02-11 11:34:53",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Financial Results For Quarter Ended Dec 31 2024",
            "news_body": "PFA unaudited financial results and LRR for quarter and nine months ended 31st Dec 2024",
            "news_id": "5cbe62c2-a5f6-4ef7-8a73-9e3b66634e22",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=062753e0-91e1-4f24-9aea-9f1bac587202.pdf",
            "news_date": "2025-02-07 14:14:53",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "PFA press release and analyst presentation on Q3FY25 earnings and business updates",
            "news_id": "fd51d195-c0f0-4e9f-a50f-7571311120fb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2fb5c609-f19d-4f1c-860b-8886d45c002d.pdf",
            "news_date": "2025-02-07 13:55:15",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Financials Results For Quarter Ended Dec 31 2024",
            "news_body": "Please find enclosed unaudited financial results and LRR for quarter and nine months ended 31st Dec 2024.",
            "news_id": "360a8f8c-dc04-418a-8ca6-e74a769f883d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86c00b50-0fba-4f99-91fe-f4d527120165.pdf",
            "news_date": "2025-02-07 13:49:39",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith the transcript of Q2 FY 2025 Earnings Conference Call hosted by the Company on 13th November, 2024.",
            "news_id": "4c3684a1-8d18-430a-9f02-d6e600dfb2e9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42c6bd93-e92a-4faf-a759-d5d6eaad0470.pdf",
            "news_date": "2024-11-18 16:35:07",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the 'Q2 H1FY25 Earnings Conference Call' is available on the website of the Company at https://www.alkemlabs.com/investors/earnings-call.",
            "news_id": "8ca67d54-f00e-4c42-a1ed-5cac4326d300",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34c1470b-5440-4155-952c-d3469c563b12.pdf",
            "news_date": "2024-11-13 21:56:08",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith press release and analyst presentation on Q2 & H1FY25 earnings and business updates of the Company.",
            "news_id": "89887af1-1d32-44fd-9248-7045be996500",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=38022e41-5563-4600-b048-ac1a5b1eb081.pdf",
            "news_date": "2024-11-13 13:23:18",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Financial Results For Quarter And Half Year Ended Sept 30, 2024.",
            "news_body": "Please find enclosed herewith the unaudited financial results and limited review report of the Company for the quarter and half year ended 30th Sept, 24.",
            "news_id": "99d8b808-1dd9-4975-87c4-ef0f98370111",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=554b9f90-845c-46ad-8d2b-784e01161985.pdf",
            "news_date": "2024-11-13 13:16:52",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith the presentation with respect to the Investors/ Analyst meetings being held today i.e. on 17th September, 2024 in Gurgaon.",
            "news_id": "5e6be3d9-59a6-4c3f-99e8-f571fd937093",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b55029a5-57d1-46ab-b826-fb2cc20bb124.pdf",
            "news_date": "2024-09-17 14:51:41",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith the transcript of Q1 FY2025 Earnings Conference Call hosted by the Company on 09th August, 2024.",
            "news_id": "9d51de12-d2dd-4443-976e-135eb76c8f69",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4b327f3-1bb1-4659-a93f-d9e4f5e73886.pdf",
            "news_date": "2024-08-12 10:45:37",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the 'Q1FY25 Earnings Conference Call' is available on the website of the Company at https://www.alkemlabs.com/investors/earnings-call.",
            "news_id": "310824a6-12a4-41e6-8873-43e4221682b1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa5ac5be-3b4e-409c-b570-b70ec1d10097.pdf",
            "news_date": "2024-08-09 20:51:09",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith press release and analyst presentation on Q1FY25 earnings and business updates of the Company.",
            "news_id": "76cf82d0-9509-4af4-8bb9-4a3e7b205be0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e90daeb3-2441-41b2-9f32-e9c9203f9d58.pdf",
            "news_date": "2024-08-09 13:16:43",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Financial Results For Quarter Ended 30Th June, 2024",
            "news_body": "Please find enclosed herewith unaudited financial results and limited review report of the Company for quarter ended 30th June, 24",
            "news_id": "47402528-07ba-4dc2-9228-4b296a3f9331",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d4b176e-bc96-4e8f-aa42-10611b0692eb.pdf",
            "news_date": "2024-08-09 13:11:37",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith the transcript of Q4 FY2024 Earnings Conference Call hosted by the Company on 29th May, 2024.",
            "news_id": "83d760f5-a3ec-4e90-a8d3-dfa5399d53cd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b6a8a6c-c6fd-4518-9793-2aa06844c420.pdf",
            "news_date": "2024-06-03 10:02:26",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the 'Q4FY24 and FY 24 Earnings Conference Call' is available on the website of the Company at https://www.alkemlabs.com/investors/earnings-call.",
            "news_id": "79e4c9b1-5c74-44fe-a600-4ad305497ab3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80a7c2af-df0b-4df3-b555-068581f0d013.pdf",
            "news_date": "2024-05-29 20:03:25",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pl. find enclosed press release and analyst presentation on Q4FY24 and FY 24 earnings and business updates of the Company",
            "news_id": "4ea76197-a667-4e36-8b59-c54fa70c2211",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc8cce9f-cfcc-46ca-87d5-d2acc6a4330b.pdf",
            "news_date": "2024-05-29 14:20:10",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results Financial For Quarter And Year Ended 31St March 24",
            "news_body": "Pl. find enclosed Audited Financial results for quarter and year ended 31st march 24",
            "news_id": "94bd2383-7c08-4db7-a44a-4ba8bbd34f28",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=500ba267-f082-4f78-86e6-0eeda41b1ac2.pdf",
            "news_date": "2024-05-29 14:12:30",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith the transcript of the ''Q3 FY2024 Earnings Conference Call'' which was hosted by the Company on Friday 09th February, 2024.The said transcript shall also be made available on the website of the Company.",
            "news_id": "8001e525-66fe-417b-8413-2c9d83ff9472",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a729b6a-62f5-4f0a-90a0-8c452be8f8e1.pdf",
            "news_date": "2024-02-14 10:21:54",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the 'Q3FY24 Earnings Conference Call' is available on the website of the Company at https://www.alkemlabs.com/earnings-call.php.Kindly take the same on records.",
            "news_id": "b109ca18-ee1f-450d-8e71-5413f73e6081",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb14e3d8-0810-45c4-9f7d-18043e3f1f9e.pdf",
            "news_date": "2024-02-09 19:41:17",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the 'Q3FY24 Earnings Conference Call' is available on the website of the Company at https://www.alkemlabs.com/earnings-call.php.Kindly take the same on records.",
            "news_id": "762574af-08a8-4d80-b4e6-6a4325563853",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37f00549-74e9-4fd7-be45-4330f75ced2e.pdf",
            "news_date": "2024-02-09 19:39:35",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith press release and analyst presentation on Q3FY24 and 9MFY24 earnings and business updates.Kindly take a note of the same.",
            "news_id": "a04ce5de-69a9-472a-bbce-dd3a5fe926c7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c6abdd99-2066-4b3e-a233-03bd1707924c.pdf",
            "news_date": "2024-02-09 13:27:32",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Financial Results For Quarter Ended December 31, 2023",
            "news_body": "Copy of Financial Results and LRR is enclosed herewith",
            "news_id": "9235be78-f838-42dc-833f-0cbb364ec0f9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61a080dd-ee43-42ab-baec-fb193522e918.pdf",
            "news_date": "2024-02-09 13:17:15",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Financial Results For Quarter Ended December 31, 2023",
            "news_body": "Copy of Financial Results and LRR is enclosed herewith",
            "news_id": "1921fd12-d666-499e-b8bf-ad6fba1d22a4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98dce704-957f-4e9e-a10c-1738fe6a36ee.pdf",
            "news_date": "2024-02-09 13:15:51",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith the transcript of the ''Q2 FY2024 Earnings Conference Call'' which was hosted by the Company on Tuesday 07th November, 2023.The said transcript shall also be made available on the website of the Company.",
            "news_id": "7652d71e-0f4f-4f25-8d0e-e1a1649da0c0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=04251ddf-241b-434e-99c2-c8a17f5acb67.pdf",
            "news_date": "2023-11-10 14:37:33",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the 'Q2FY24 Earnings Conference Call' is available on the website of the Company at  https://www.alkemlabs.com/earnings-call.php.",
            "news_id": "0f79d8ba-ef13-46b3-acbd-c04c8478e5f8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e9515c11-9e7f-4fa4-b348-da9062427aff.pdf",
            "news_date": "2023-11-08 10:21:32",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed press release and analyst presentation on Q2FY24 earnings and business updates and the same shall be uploaded on website of the Company",
            "news_id": "32936885-2961-46de-8b40-83d5cb9b1f6d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f61311b-2324-4b47-afbe-1f85bb4b2e39.pdf",
            "news_date": "2023-11-07 14:01:28",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Financial Results For Quarter Ended September 30, 2023",
            "news_body": "Please find attached herewith copy of unaudited financial results and limited review of the Statutory Auditors is enclosed herewith",
            "news_id": "ea49b5b1-720f-4938-9f1c-7da6c19a32bd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84fb1758-9740-47cd-be6b-6c16594aa067.pdf",
            "news_date": "2023-11-07 13:50:59",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith the transcript of the Q1 FY 2024 Earnings Conference Call which was hosted by the Company on Thursday, 10th August, 2023.The said transcript shall also be made available on the website of the Company.Kindly take the same on record.",
            "news_id": "f0bf268f-7b0a-4e32-82f6-e638f674f9d0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1cb590b5-427a-4ddc-bd47-eac8f95b73d6.pdf",
            "news_date": "2023-08-14 15:40:29",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the 'Q1FY24 Earnings Conference Call' is available on the website of the Company at https://www.alkemlabs.com/earnings-call.php.Kindly take the same on records.",
            "news_id": "0b23708f-9d33-4506-a20d-afbd6cc389dc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=15e4fcd2-3ba0-4e2d-a42a-22c9ae6770f8.pdf",
            "news_date": "2023-08-10 19:50:21",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "With reference to relevant provisions of SEBI LODR Reg, 2015 we enclose herewith press release and analyst presentation on Q1FY24 earnings and business updates and the same shall be uploaded on the website of the Company.",
            "news_id": "36f2ad97-368c-4fa4-8383-d1d877a55f86",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1917016f-4c42-42cf-8084-d75d804ca031.pdf",
            "news_date": "2023-08-10 14:00:17",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Financial Results For Quarter Ended June 30, 2023",
            "news_body": "Kindly refer to our intimation letter dated 31st July 23 pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (LODR) Reg, 2015. We are enclosing the Standalone and Consolidated Unaudited Financial Results for the quarter ended 30th June 23 duly approved by the BOD of the Company at its meeting held today i.e 10th Aug, 23. A copy of the Unaudited Financial Results and Limited Review Report is enclosed herewith. The meeting of BOD commenced at 11.45 and concluded at 1.45 pm.",
            "news_id": "c46f96d2-9581-411a-9bbe-a2bc8af45e0b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b211402-5855-473a-8419-cb2b1480134b.pdf",
            "news_date": "2023-08-10 13:56:45",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Dated 10Th Aug 23",
            "news_body": "The Board of Directors of the Company, at its meeting held today, i.e. 10.08.2023 have approved the Standalone and Consolidated Unaudited Financial Results for the QE 30.06 2023. A copy of the said Financial Results and Limited Review Report of the Statutory Auditors of the Company, as required under Reg 33 of the Listing Regulations, is enclosed herewith. The meeting of the Board of Directors of the Company commenced at 11.45 A.M and concluded at 1.45 P.M.<BR> <BR> Kindly take the same on record.  <BR>",
            "news_id": "b86b9cef-1810-4edc-8109-055bee43c880",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a0e04d1-bbb3-4de7-95d3-5c60df20efb3.pdf",
            "news_date": "2023-08-10 13:46:40",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith the transcript of the 'Q4 FY2023 Earnings Conference Call' which was hosted by the Company on Friday, 19th May, 2023. The said transcript shall also be made available on the website of the Company.Kindly take the same on record.",
            "news_id": "d3c2c433-502d-41d2-ac84-386a5eaf7b07",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=953eeb0a-bdad-465b-aca0-d37297ba76ee.pdf",
            "news_date": "2023-05-22 16:10:00",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the 'Q4FY23 and FY23 Earnings Conference Call' is available on the website of the Company at https://www.alkemlabs.com/earnings-call.php.Kindly take the same on records.",
            "news_id": "edfdd552-113d-4c2d-9f8f-05773463600c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=111a402f-3265-49ef-a071-5c1bd02a1cec.pdf",
            "news_date": "2023-05-19 18:23:18",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q4FY23 and FY23 earnings and business updates and the same will be uploaded on the website of the Company.Kindly take note of the same.",
            "news_id": "3aa65107-93d7-47be-a493-1017cce44160",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2888506-523d-4069-b528-da0388eb43d1.pdf",
            "news_date": "2023-05-19 14:15:42",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Financial Results For Quarter And Year Ended March 31, 23",
            "news_body": "In continuation of our letter dated 9th May, 2023 and pursuant to Regulation 30 read with Regulation 33 of the SEBI LODR Regulations, the Board of Directors of the Company, at its meeting held today, i.e. 19th May, 2023, has inter alia approved the Standalone and Consolidated Audited Financial Statements for the quarter and financial year ended 31st March, 2023.The Company hereby declares that the Auditors have expressed an unmodified opinion in the Audit Reports on Standalone and Consolidated Financial Results for the quarter and financial year ended 31st March, 2023.The meeting of the Board of Directors of the Company commenced at 11.00 A.M and concluded at 1.30 P.M.",
            "news_id": "b42dd357-311c-4edf-a52d-be7fe3984977",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=95e8d3c5-e1a8-458c-9ac8-5d994b67b936.pdf",
            "news_date": "2023-05-19 13:46:49",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "We enclose herewith the transcript of the 'Q3 FY2023 Earnings Conference Call' which was hosted by the Company on Friday, 10th February, 2023. The said transcript shall also be made available on the website of the Company. Kindly take the same on record",
            "news_id": "dd0bf516-df92-463c-af65-76b1237ee815",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d3e82fe6-971a-465e-aff2-fb4d4e74f1f5.pdf",
            "news_date": "2023-02-15 10:28:46",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the 'Q3FY23 Earnings Conference Call' is available on the website of the Company at https://www.alkemlabs.com/earnings-call.php.Kindly take the same on records.",
            "news_id": "95bcb610-06a3-4507-a439-5e518893a684",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1feee0a8-496a-42ac-8cbb-80e4c14509d4.pdf",
            "news_date": "2023-02-10 20:15:53",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q3FY23 and 9MFY23 earnings and business updates and the same will be uploaded on the website of the Company.Kindly take note of the same.",
            "news_id": "6b6eb164-882f-4f0b-b6a3-bd4747f6d0e9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90b78f93-c59a-4cb8-b3e4-7a25d0672bf1.pdf",
            "news_date": "2023-02-10 13:52:19",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Financial Results For Quarter And Nine Months Ended December 31, 2022",
            "news_body": "In continuation of our letter dated 24th January, 2023 and pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the Company, at its meeting held today, i.e. 10th February, 2023 have inter alia approved the Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended 31st December, 2022.A copy of the said Financial Results and Limited Review Report of the Statutory Auditors of the Company, as required under Reg 33 of the Listing Regulations, is enclosed herewith.The meeting of the Board of Directors of the Company commenced at 11.00 a.m. and concluded at 01.10 p.m.Kindly take the same on record.",
            "news_id": "30e45efc-2ac6-47b3-8575-b895aabb44d4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f79a8680-50b3-4f6b-a877-abc27fe5250a.pdf",
            "news_date": "2023-02-10 13:39:25",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosure on a consolidated basis, for the half year ended on 30th September, 2022 in the prescribed format. The same have been published on the website of the Company at www.alkemlabs.com.Kindly take the same on record.",
            "news_id": "fc9b0a9a-4886-4ea0-ad19-898a11f8c898",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5ee3fef9-a90a-4f82-ae9d-01f36bd26143.pdf",
            "news_date": "2022-11-25 16:52:08",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "We enclose herewith the transcript of the 'Q2 FY2023 Earnings Conference Call' which was hosted by the Company on Friday, 11th November, 2022. The said transcript shall also be made available on the website of the Company.Kindly take the same on record.",
            "news_id": "47007d38-0547-48f2-8d71-66601d94aabc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18899cba-4450-4c91-8659-44dba664fe05.pdf",
            "news_date": "2022-11-14 11:57:28",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the 'Q2FY23 Earnings Conference Call' is available on the website of the Company at  https://www.alkemlabs.com/earnings-call.php. Kindly take the same on records.",
            "news_id": "cb4d2892-07e0-490b-8cdf-b98b95d9043d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29c5a0ab-07c9-4c39-a747-7d846d27bd0a.pdf",
            "news_date": "2022-11-11 19:49:03",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q2FY23 earnings and business updates and the same will be uploaded on the website of the Company.Kindly take note of the same.",
            "news_id": "714a1d03-df4b-4742-b32b-0c16a491e08a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e1882a98-5911-4f7e-b680-017fca63277a.pdf",
            "news_date": "2022-11-11 13:33:25",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Financial Results For Quarter Ended September 30, 2022",
            "news_body": "In continuation of our letter dated 02nd November, 2022 and pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), the Board of Directors of the Company, at its meeting held today, i.e. 11th November, 2022 have inter alia approved the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended 30th September, 2022.<BR> <BR> A copy of the said Financial Results and Limited Review Report of the Statutory Auditors of the Company, as required under Regulation 33 of the Listing Regulations is enclosed herewith.<BR> <BR> The meeting of the Board of Directors of the Company commenced at 11.00 A.M and concluded at 1.15 P.M.<BR> <BR> Kindly take the same on record.<BR>",
            "news_id": "2ff776cf-7706-4e84-8ee4-6cdb74b80851",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=064195b8-5d27-4726-a70f-ad02ff87e503.pdf",
            "news_date": "2022-11-11 13:27:26",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "We enclose herewith the transcript of the Q1 FY2023 Earnings Conference Call which was hosted by the Company on Friday, 05th August, 2022.The said transcript shall also be made available on the website of the Company.Kindly take the same on record.",
            "news_id": "318ccf72-e34b-44af-ac44-cb3ab26d3b8a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0bf08335-16c7-48e2-adcf-39b500dbae79.pdf",
            "news_date": "2022-08-10 10:42:50",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q1FY23 earnings and business updates and the same will be uploaded on the website of the Company.Kindly take note of the same.",
            "news_id": "d05dcdf0-6ea2-4ec4-962d-f2a44732b757",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=605f3032-0343-4cf6-a3c9-5603e431b89d.pdf",
            "news_date": "2022-08-05 13:35:34",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Financial Results For Quarter Ended June 30, 2022",
            "news_body": "In continuation of our letter dated 25th July, 2022 and pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), the Board of Directors of the Company, at its meeting held today, i.e. 05th August, 2022 have inter alia approved the Standalone and Consolidated Unaudited Financial Results for the quarter ended 30th  June, 2022.<BR> <BR> A copy of the said Financial Results and Limited Review Report of the Statutory Auditors of the Company, as required under Regulation 33 of the Listing Regulations, is enclosed herewith.<BR> <BR> The meeting of the Board of Directors of the Company commenced at 11.00 A.M and concluded at 1.20  P.M.<BR> <BR> KIndly take the same on record.",
            "news_id": "d3c95010-5e18-4f7d-9db7-17f7651d8edb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84dd32ca-8992-4188-ace2-c3ce4c68369a.pdf",
            "news_date": "2022-08-05 13:27:53",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Dated 05/08/2022",
            "news_body": "The Board of Directors of the Company, at its meeting held today, i.e. 05.08.2022 have inter alia:<BR> <BR> 1. approved the Standalone and Consolidated Unaudited Financial Results for the quarter ended 30.06 2022.<BR> <BR> A copy of the said Financial Results and Limited Review Report of the Statutory Auditors of the Company, as required under Reg 33 of the Listing Regulations, is enclosed herewith.<BR> <BR> 2. based on recommendation of Nomination and Remuneration Committee and subject to approval of shareholders, approved the appointment of Mr. Sujjain Talwar (DIN: 01756539) as an Additional Director designated as an Independent Director on the Board of Directors of the Company for a period of five (5) consecutive years with effect from 05.08.2022 to 04.08.2027.<BR> <BR> The meeting of the Board of Directors of the Company commenced at 11.00 A.M and concluded at  1.20 P.M.<BR> <BR> Kindly take the same on record.",
            "news_id": "4d7819df-7e41-4b41-9d85-5bcd3581f210",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f920132-1602-4ec9-b87d-ca2ee7bb121d.pdf",
            "news_date": "2022-08-05 13:23:54",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions On A Consolidated Basis Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosures of related party transactions, on a consolidated basis, for the half year ended on 31st March, 2022 in the prescribed format.The same have been published on the website of the Company at www.alkemlabs.com.Kindly take the same on record.",
            "news_id": "d5d36507-336d-4bf6-9fa4-a5151c4f878a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d5bb3d7-9f4a-4d51-8e2f-b1fb3b7e9658.pdf",
            "news_date": "2022-05-25 14:50:47",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "We enclose herewith the transcript of the 'Q4 FY2022 Earnings Conference Call' which was hosted by the Company on Friday, 13th May, 2022.  The said transcript shall also be made available on the website of the Company.Kindly take the same on record.",
            "news_id": "ba310b17-7a80-4f6a-8078-652363a5c933",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9663f31-d251-40a6-a20a-1821a8cba521.pdf",
            "news_date": "2022-05-16 17:01:34",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the 'Q4FY22 and FY22 Earnings Conference Call' is available on the website of the Company.Kindly take the same on records.",
            "news_id": "be7f37df-10e1-45d9-9ad4-afa3c69a37b9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc4b78e3-531b-4a8e-ad09-116e327813c1.pdf",
            "news_date": "2022-05-13 20:57:31",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q4FY22 and FY22 earnings and business updates and the same will be uploaded on the website of the Company.Kindly take note of the same.",
            "news_id": "9673ed2e-76b0-449f-84ef-3e2514428cd1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe249677-24fb-42b4-b4d6-674982cf57ab.pdf",
            "news_date": "2022-05-13 13:56:10",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Financial Results For Quarter And Year Ended March 31, 22",
            "news_body": "In continuation of our letter dated 28th April, 2022 and pursuant to Regulation 30 read with Regulation 33 of the SEBI LODR (''Listing Regulations'') the Board of Directors of the Company, at its meeting held today, i.e. 13th May, 2022, has inter alia approved the Standalone and Consolidated Audited Financial Results for the quarter and financial year ended 31st March, 2022. Accordingly, we are enclosing herewith Standalone and Consolidated Audited Financial Results for the quarter and financial year ended 31st March, 2022 and the Auditor''s Report thereon. The Company hereby declares that the Auditors have expressed an unmodified opinion in the Audit Reports on Standalone and Consolidated Financial Results for the quarter and financial year ended 31st March, 2022. The meeting of the Board of Directors of the Company commenced at 11.00 A.M and concluded at 1.30  P.M. Kindly take the same on record.<BR>",
            "news_id": "7312f7b2-4d1c-4a9e-8a08-6b70e982a11c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dad6ebdc-5f5c-49f1-b111-c232602451f9.pdf",
            "news_date": "2022-05-13 13:47:02",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith the transcript of the 'Q3 FY2022 Earnings Conference Call' which was hosted by the Company on Friday, 04th February, 2022.  The said transcript shall also be made available on the website of the Company.Kindly take the same on record.",
            "news_id": "800cf643-4466-4726-9065-0ea13aeca71b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77d1d096-8051-4e43-b501-78cf154027e1.pdf",
            "news_date": "2022-02-09 12:46:25",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q3FY22 and 9MFY22 earnings and business updates and the same will be uploaded on the website of the Company.Kindly take note of the same.",
            "news_id": "4d2d4ca2-7b80-4009-baa9-4ca65246f60e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a7c4031-ceb8-430d-beb2-025767387d98.pdf",
            "news_date": "2022-02-04 13:20:06",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Financial Results For Quarter And Nine Months Ended 31St Dec 2021.",
            "news_body": "In continuation of our letter dated 24th January, 2022 and pursuant to Regulation 30 read with Regulation 33 and Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 , the Board of Directors of the Company, at its meeting held today, i.e. 04th February, 2022 have inter alia approved the Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended 31st Dec, 2021.<BR> <BR> A copy of the said Financial Results and Limited Review Report of the Statutory Auditors of the Company, as required under Reg 33 of the Listing Regulations, is enclosed herewith.<BR> <BR> The meeting of the Board of Directors of the Company commenced at 10.30 a.m. and concluded at 01.00 pm.<BR>",
            "news_id": "86cfa3ba-4806-43d7-b8e0-9e3e72da4dcb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec338b1f-08aa-425f-a921-cbbad8dd8e70.pdf",
            "news_date": "2022-02-04 13:15:02",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Dated 04/02/2022",
            "news_body": "The Board of Directors of the Company, at its meeting held today, i.e. 04th February, 2022 have inter alia:<BR> <BR> a.  Approved the Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended 31st December, 2021. <BR> <BR> b.  Declared Interim Dividend of Rs  30/- (Rupees Thirty only) per equity share on the face value of Rs. 2/- per share for the financial year 2021-22 pursuant to Regulation 43 read with Regulation 30 of the Listing Regulations. <BR>  <BR>   <BR> The meeting of the Board of Directors of the Company commenced at 10.30 a.m. and concluded at 01.00 p.m.<BR> <BR> <BR> Kindly take the same on record.<BR>",
            "news_id": "d03e304d-3593-4d59-975b-584961d57382",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bec7b971-9a80-487d-a2df-488a6b14ebc3.pdf",
            "news_date": "2022-02-04 13:10:27",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions On A Consolidated Basis Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosures of related party transactions, on a consolidated basis, for the half year ended on 30th September, 2021 in the prescribed format.<BR> <BR> The same have been published on the website of the Company at www.alkemlabs.com.<BR> <BR> Kindly take the same on record.<BR>",
            "news_id": "ef95f522-664b-4780-be8f-ecde66163761",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0efc197c-0644-4290-8de3-41c69f46f184.pdf",
            "news_date": "2021-11-30 15:28:08",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "We enclose herewith the transcript of the 'Q2 FY2022 Earnings Conference Call' which was hosted by the Company on Friday, 12th November, 2021.  <BR> <BR> The said transcript shall also be made available on the website of the Company.<BR> <BR> Kindly take the same on record.<BR>",
            "news_id": "84001899-0c9b-4cd5-b584-e337c33a08b7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bfe8bf0c-dcef-49e3-b500-d207c7457719.pdf",
            "news_date": "2021-11-15 14:06:35",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q2FY22 and H1FY22 earnings and business updates and the same will be uploaded on the website of the Company.<BR> <BR> Kindly take note of the same.<BR>",
            "news_id": "a8c17687-d990-4735-8ff2-5c7fccaf41e9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6aec5f3a-da7b-4abb-9001-a684c59fe984.pdf",
            "news_date": "2021-11-12 12:53:50",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Financial Results For Quarter And Half Year Ended September 30, 2021",
            "news_body": "In continuation of our letter dated 02nd November, 2021 and pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we are enclosing the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended 30th September, 2021, duly approved by the Board of Directors of the Company, at its meeting held today, i.e. 12th November, 2021. The meeting of the Board of Directors of the Company commenced at 10.00 A.M and concluded at 12.30  P.M. A copy of the Limited Review Report of the Statutory Auditors of the Company, as required under Regulation 33 of the Listing Regulations, is also enclosed herewith. Kindly take the same on record. <BR>",
            "news_id": "ead01f1a-4180-4ac1-a6f2-2fc79e341745",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c641900b-15ae-4c1f-8a46-94cab8a509a9.pdf",
            "news_date": "2021-11-12 12:50:49",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Dated 12/11/2021",
            "news_body": "The Board of Directors at its meeting held today i.e. 12th November, 2021, has approved the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended 30th September, 2021.<BR> <BR> Accordingly, we are enclosing herewith Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended 30th September, 2021 and the Limited Review Report of the Statutory Auditors of the Company. The meeting of the Board of Directors of the Company commenced at 10 am and concluded at 12.30 pm. <BR>",
            "news_id": "f711e49b-0252-4f48-ba10-025edec1ade1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=adef3833-a162-459a-9dfb-3761b5b1bddd.pdf",
            "news_date": "2021-11-12 12:42:20",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q1FY22 earnings and business updates and the same will be uploaded on the website of the Company.<BR> <BR> Kindly take note of the same.<BR>",
            "news_id": "92f133dc-5a26-4873-9805-400925376d50",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ed557e8-669f-44f4-872f-13b7f9a326e2.pdf",
            "news_date": "2021-08-06 13:43:56",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Financial Results For Quarter Ended June 30, 2021",
            "news_body": "In continuation of our letter dated 26th July, 2021 and pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we are enclosing the Standalone and Consolidated Unaudited Financial Results for the quarter ended 30th June, 2021, duly approved by the Board of Directors of the Company, at its meeting held today, i.e. 06th August, 2021. The meeting of the Board of Directors of the Company commenced at 11.00 A.M and concluded at 1.30  P.M.<BR> <BR> A copy of the Limited Review Report of the Statutory Auditors of the Company, as required under Regulation 33 of the Listing Regulations, is also enclosed herewith.<BR> <BR> Kindly take the same on record.<BR>",
            "news_id": "986fdb52-8d81-4d97-8818-ed57b2d19ca5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5249c44a-b87b-419c-8a85-a29b032a9f7e.pdf",
            "news_date": "2021-08-06 13:41:53",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Dated 6Th Aug, 2021<BR>",
            "news_body": "The Board of Directors at its meeting held today i.e. 06th August, 2021, has approved the Standalone and Consolidated Unaudited Financial Results for the quarter ended 30th June, 2021.<BR> Accordingly, we are enclosing herewith Standalone and Consolidated Unaudited Financial Results for the quarter ended 30th June, 2021 and the Limited Review Report of the Statutory Auditors of the Company. The meeting of the Board of Directors of the Company commenced at 11 am and ended at 1. 30 pm.    <BR>",
            "news_id": "76d98b4f-de35-4da9-aef2-9b980d66a338",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0bf8b35e-c69a-4be9-8d29-03cdf24cef86.pdf",
            "news_date": "2021-08-06 13:35:47",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions On A Consolidated Basis Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosures of related party transactions, on a consolidated basis, for the half year ended on 31st March, 2021 in the prescribed format.<BR> <BR> The same have been published on the website of the Company at www.alkemlabs.com.<BR> <BR> Kindly take the same on record.",
            "news_id": "7769aed0-099a-48ee-8664-38b1f634055b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41e82d38-2c00-41df-aba0-8f7f84579e6b.pdf",
            "news_date": "2021-06-09 19:17:10",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q4FY21 and FY21 earnings and business updates and the same will be uploaded on the website of the Company.<BR> <BR> Kindly take note of the same.<BR>",
            "news_id": "50776f8f-9324-40c5-8a57-e3553916f4ce",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3377b4de-ead0-46a3-9cc7-693607bffc81.pdf",
            "news_date": "2021-05-25 14:08:50",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financial Results For Quarter And Year Ended March 31, 21",
            "news_body": "continuation of our letter dated 14th May, 2021 and pursuant to Regulation 30 read with Regulation 33 of the SEBI LODR (''Listing Regulations'') the Board of Directors of the Company, at its meeting held today, i.e. 25th May, 2021, has inter alia: .<BR> 1. Approved the Standalone and Consolidated Audited Financial Results for the quarter and financial year ended 31st March, 2021.<BR> <BR> Accordingly, we are enclosing herewith Standalone and Consolidated Audited Financial Results for the quarter and financial year ended 31st March, 2021 and the Auditor''s Report thereon.<BR> <BR> The Company hereby declares that the Auditors have expressed an unmodified opinion in the Audit Reports on Standalone and Consolidated Financial Results for the quarter and financial year ended 31st March, 2021.<BR> <BR> The meeting of the Board of Directors of the Company commenced at 11.00 A.M and concluded at 1.45 P.M<BR> Kindly take the same on record.<BR>",
            "news_id": "f6f7453f-6e38-4f12-ae49-1467107a3a25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3b5cc5a-60f4-4cc9-91bf-fa23a32a41b4.pdf",
            "news_date": "2021-05-25 14:00:34",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALKEM",
            "disp": "Alkem Laboratories",
            "bse_code": 539523,
            "isin": "INE540L01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Dated 25/05/2021",
            "news_body": "The BOD at its meeting held today i.e. 25.05.21  has, inter alia approved the Standalone and Consolidated Audited Financial Statements  for the quarter and FY  ended 31.3.21 and other items as enclosed herewith.",
            "news_id": "479ff953-51f9-4e1f-9f0e-302a54a26007",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c71a9699-d3ac-4a3c-8a12-5931c4e84843.pdf",
            "news_date": "2021-05-25 13:56:15",
            "seo": "alkem-laboratories-ltd",
            "ltp": 5890,
            "ch": 78.5,
            "pch": 1.350770024950529,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 11703,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}